BioSig Technologies to Attend the Benchmark Company Micro Cap Discovery Conference
(firmenpresse) - MINNEAPOLIS, MN -- (Marketwired) -- 12/03/15 -- (OTCQB: BSGM) today announced that it will be participating at the Benchmark Company, LLC Micro Cap Discovery Conference on Thursday, December 10, 2015 in Chicago. Executive Chairman, Ken Londoner, President and CEO, Greg Cash, and VP of Clinical Research, Jay Millerhagen will be in attendance.
The conference is being held at the Palmer House Hilton Hotel 17 E. Monroe Chicago, IL.
BioSig Technologies is a that is developing a proprietary technology platform designed to improve the $3 billion electrophysiology (EP) marketplace(1) (). Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP System.
PURE EP System is a surface electrocardiogram and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used to guide the EPs in identifying ablation targets -- areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia).
Analysts forecast the global market for will grow at a 12.1 percent compound annual growth rate, from $2.5 billion in 2012 to $5.5 billion by 2019(1) -- making it one of the fastest growing medical device segments. Just in the US, the number of Atrial Fibrillation (AF) and Ventricular Tachycardia (VT) arrhythmia ablations is forecast to grow at 10.5 percent from 2012 to 2017(2).
BioSig intends to seek FDA 510(k) clearance for the PURE EP System. The Company has achieved proof of concept validation through UCLA labs, and has performed pre-clinical studies at the Mayo Clinic in Minnesota. The Company is collaborating with several of the nation's most prestigious cardiac arrhythmia centers including Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, and Mayo Clinic.
(1) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
(2) HRI 2013 "Global Opportunities in Medical Devices & Diagnostics" report; triangulation of multiple sources; *AF includes left atrial tachycardia, left WPW, left atrial flutter.
Brian McLaughlin
BioSig Technologies, Inc.
917-370-9817
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.12.2015 - 13:00 Uhr
Sprache: Deutsch
News-ID 437307
Anzahl Zeichen: 5715
contact information:
Town:
MINNEAPOLIS, MN
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 673 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioSig Technologies to Attend the Benchmark Company Micro Cap Discovery Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
BioSig Technologies, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
